Arkansas Blood Institute Collecting Convalescent Plasma to Aid Local COVID-19 Patients

Arkansas Blood Institute (ABI) is collecting convalescent plasma from donors who have recovered from COVID-19, part of an experimental initiative to use the product to treat seriously ill patients.

By creating a registry of available patients, Arkansas Blood Institute can ensure local patients receive the donated products and have the best possible chance at fighting the illness.

“We’re excited to play our part in ensuring patients have access to all treatment options, including convalescent plasma,” said John Armitage, MD, president and CEO of Arkansas Blood Institute. “As the local community blood supplier, we can quickly collect donor information and work with our hospital partners to ensure anyone who wants to help a neighbor has that opportunity.”

Donors are encouraged to sign up for the registry at my.bio-linked.org. Bio-Linked allows users to submit confidential health and social information via a secure site and to list themselves as potential volunteers for medical research. Once qualified, plasma will be drawn, with each donor providing up to three therapeutic plasma doses.

    To provide convalescent plasma, donors must meet the criteria below:
  • Have a prior diagnosis of COVID-19, documented by a laboratory test
  • Be symptom-free for 14 days prior to donation and test negative for COVID-19 (testing will be provided, if needed)
  • Be eligible to donate blood

“In this time of need, we must all unite to fight against this pandemic threat,” Armitage said. “At Arkansas Blood Institute, we’re proud to continue our role as a leading provider of public health services and cutting-edge care for our state’s patients.”

 

Bob Grant